Cross-institution positioning
Jul 31, 2026Reduction leaning. 2 reducing across 2 comparable institutions.
Source: Schedule 13 researchRANI Institutional Ownership
Rani Therapeutics Holdings, Inc.
Latest stored close $0.81 as of Oct 7, 2026 View live quote ↗
STOCKNODE Outlook
Sell
35/100
2 tracked · 2 comparable
Latest filing
Jul 31, 2026
Positive breadth
0 positive · 2 negative
Recent close
$0.81
Research confidence
Limited
Institutional Research 25/100 · 0 accumulating · 2 reducing / exited
Ownership history
Reported ownership % history
Latest filing Jul 31, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating0
Newly reported0
Reducing / exited
2
52-week position
—
Institutional Intelligence
Why STOCKNODE says Sell
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Sell 35/100
Confidence:Limited
Why this signal
- 0 tracked institutions accumulating versus 2 reducing/exited.
- Recent insider purchase activity confirms the institutional direction.
Conflicting evidence
- Institutions are reducing while recent insider P/S activity leans bullish.
Institutional
24/100
Insiders
68/100
Fundamentals
39/100
Events
50/100
Quarterly 13F activity
Jun 30, 20260 increased/new, 1 reduced/exited, and 1 unchanged across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Sep 27, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 2 purchases by 2 reporting owners and 0 sales by 0 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Aug 13, 20263 non-amendment material events in the last 90 days; 1 capital-related filing/event (1 equity-related, 0 debt-related); Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Aug 13, 2026Net income -10.4% YoY; Free cash flow -11.0% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 11% through its reported 52-week range; +68.4% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from Vanguard Capital Management.
Filed Jul 31, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Jul 31, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Vanguard Capital Management
Filed Jul 31, 2026
Direction locked
Vanguard Group
Filed Mar 27, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Vanguard Capital Management
Filed Jul 31, 2026
Vanguard Group
Filed Mar 27, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales00 reporting owner(s)
90-day purchase breadth2Multi-insider
90-day sale breadth0
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 27, 2026 | Javadi Alireza | FTax/price withholding or payment | Class A Common Stock | 309 | $0.76 | Direct | Sep 29, 2026 |
| Sep 27, 2026 | Imran Talat | FTax/price withholding or payment | Class A Common Stock | 7.9K | $0.76 | Direct | Sep 29, 2026 |
| Aug 3, 2026 | Gilson Michelle | AGrant, award, or other acquisition · derivative | Director Stock Option (Right to Buy) | 247.2K | $0.00 | Direct | Aug 4, 2026 |
| Jul 21, 2026 | IMRAN MIR A | POpen-market or private purchase | Class A Common Stock | 36.0K | $0.69 | Direct | Jul 23, 2026 |
| Jul 17, 2026 | Imran Talat | POpen-market or private purchase | Class A Common Stock | 35.0K | $0.72 | Direct | Jul 21, 2026 |
| Jul 17, 2026 | Maestas Nicholas | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 2.0M | $0.00 | Direct | Jul 21, 2026 |
| Jun 27, 2026 | Javadi Alireza | FTax/price withholding or payment | Class A Common Stock | 309 | $0.74 | Direct | Jul 21, 2026 |
| Jun 27, 2026 | Imran Talat | FTax/price withholding or payment | Class A Common Stock | 7.9K | $0.74 | Direct | Jul 21, 2026 |
| Jun 3, 2026 | McKinley Kate | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 805.5K | $0.00 | Direct | Jun 5, 2026 |
| Jun 3, 2026 | Javadi Alireza | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 805.5K | $0.00 | Direct | Jun 5, 2026 |
| Jun 3, 2026 | Imran Talat | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 3.8M | $0.00 | Direct | Jun 5, 2026 |
| May 28, 2026 | Bassan Abraham | AGrant, award, or other acquisition · derivative | Director Stock Option (Right to Buy) | 123.6K | $0.00 | Direct | Jun 1, 2026 |
| May 28, 2026 | Rometty Lisa Ann | AGrant, award, or other acquisition · derivative | Director Stock Option (Right to Buy) | 123.6K | $0.00 | Direct | Jun 1, 2026 |
| May 28, 2026 | IMRAN MIR A | AGrant, award, or other acquisition · derivative | Director Stock Option (Right to Buy) | 123.6K | $0.00 | Direct | Jun 1, 2026 |
| May 28, 2026 | BUTEL JEAN LUC | AGrant, award, or other acquisition · derivative | Director Stock Option (Right to Buy) | 123.6K | $0.00 | Direct | Jun 1, 2026 |
| May 28, 2026 | Bailey Vasudev Jaiprakash | AGrant, award, or other acquisition · derivative | Director Stock Option (Right to Buy) | 123.6K | $0.00 | Direct | Jun 1, 2026 |
| May 28, 2026 | Ausiello Dennis A | AGrant, award, or other acquisition · derivative | Director Stock Option (Right to Buy) | 123.6K | $0.00 | Direct | Jun 1, 2026 |
| Mar 27, 2026 | Javadi Alireza | SOpen-market or private sale | Class A Common Stock | 386 | $0.78 | Direct | Jul 21, 2026 |
| Mar 27, 2026 | Imran Talat | FTax/price withholding or payment | Class A Common Stock | 9.1K | $0.81 | Direct | Jul 21, 2026 |
| Mar 22, 2026 | Imran Talat | FTax/price withholding or payment | Class A Common Stock | 8.9K | $1.13 | Direct | Jul 21, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events0
90-day capital-related1
90-day equity-related1
90-day debt-related0
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 13, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Aug 4, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Jul 15, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jun 30, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| May 29, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 27, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| May 27, 2026 | 424B5 | — | Prospectus filing | Capital-related | Filing |
| May 15, 2026 | 8-K | 2.02, 3.01, 5.02, 9.01 | Results of operations / financial condition; Listing or continued-listing notice; Director or executive change; Financial statements / exhibits | — | Filing |
| Mar 26, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Mar 26, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jan 2, 2026 | 8-K | 1.02, 3.03, 5.03, 5.07, 9.01 | Termination of material agreement; Material modification of security-holder rights; Charter or bylaw change; Shareholder vote results; Financial statements / exhibits | Equity | Filing |
| Dec 3, 2025 | 424B5 | — | Prospectus filing | Capital-related | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$1.7M
Q2 2026
10-Q filed Aug 13, 2026
Operating income
$-8.8M
Q2 2026
+16.0% YoY 10-Q filed Aug 13, 2026
Operating margin
-516.9%
Q2 2026
10-Q filed Aug 13, 2026
Net income
$-7.4M
Q2 2026
-10.4% YoY 10-Q filed Aug 13, 2026
Diluted EPS
$-0.04
Q2 2026
+77.8% YoY 10-Q filed Aug 13, 2026
Operating cash flow
$-15.5M
YTD through Jun 30, 2026
-11.3% YoY 10-Q filed Aug 13, 2026
Free cash flow
$-15.6M
YTD through Jun 30, 2026
-11.0% YoY 10-Q filed Aug 13, 2026
Cash & equivalents
$4.9M
As of Jun 30, 2026
-52.3% YoY 10-Q filed Aug 13, 2026
Long-term debt
$0
As of Dec 31, 2025
-100.0% YoY 10-K filed Mar 26, 2026
Assets
$60.8M
As of Jun 30, 2026
+260.1% YoY 10-Q filed Aug 13, 2026
Liabilities
$12.9M
As of Jun 30, 2026
-50.6% YoY 10-Q filed Aug 13, 2026
Stockholders’ equity
$39.2M
As of Jun 30, 2026
+803.7% YoY 10-Q filed Aug 13, 2026
View recent revenue trend
Quarterly
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $1.7M | — |
| Ended Mar 31, 2026 | $1.7M | +893.0% |
| Ended Sep 30, 2025 | $0 | — |
| Ended Jun 30, 2025 | $0 | — |
Annual
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $1.6M | +58.9% |
| Ended Dec 31, 2024 | $1.0M | — |
| Ended Dec 31, 2023 | $0 | — |
| Ended Dec 31, 2022 | $0 | -100.0% |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$0.82
View live quote ↗
52-week low
$0.45
Oct 13, 2025
52-week high
$3.87
Oct 22, 2025
Below 52-week high
78.8%
1W return
-5.8%
1M return
+3.3%
3M return
+7.0%
6M return
-37.7%
YTD return
-39.1%
1Y return
+68.4%
30-day volatility
52.1%
90-day volatility
85.7%
1Y max drawdown
-77.8%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 6 filing(s) · 3 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 4.6M | $0.81 | |||
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 observed Jul 31, 2026 filed · 31d Schedule 13G amendment | Reported reduction | 5.1M -56.5K | 12.00% 0.00 pts | $0.76 | $0.77 | $0.81 |
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 30, 2026 filed · 30d Initial Schedule 13G | Initial Schedule 13G | 5.1M | 12.00% | $0.74 | $0.89 | $0.81 |
Explore more institutional activity
Related research
Compare RANI with other securities showing similar institutional activity or recent accumulation across several tracked institutions.